返回
L
Liang Chen
department of physics
40H指数
351论文数
7.1K被引数
收录论文 128
发表时间
Efficacy and Safety of the Third-Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell Transplantation第三代酪氨酸激酶抑制剂Olverembatinib与Inotuzumab Ozogamicin联合治疗成人费城染色体阳性急性淋巴细胞白血病患者的疗效与安全性:适用于难治/复发疾病或持续性微小残留病,作为桥接造血干细胞移植的方案。

